ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

Platelet Disorders and von Willebrand Disease

Theme Navigation

  • ISTH 2020 Congress
    • Platelet Disorders and von Willebrand Disease
      • Acquired Thrombocytopenias
      • Antiplatelet Therapy
      • HIT
      • Inherited Thrombocytopenias
      • Platelet Antagonists and Novel Therapeutics
      • Platelet Function Disorders, Acquired
      • Platelet Function Disorders, Hereditary
      • von Willebrand Factor Biology
      • VWF and von Willebrand Factor Disorders - Clinical Conditions

Abstract Number: PB1473

«Aspirin-Like» Platelet Defect Induced by Gabapentin: A Case-Report

T. Baglo1, C. Vayne1,2, J.-B. Valentin1, L. Ardillon1, E.-A. Guery1, Y. Gruel1,2, C. Pouplard1,2

Abstract Number: PB1453

Ex vivo Observation of Platelet-granulocytes Interactions in Pediatric Patients with Congenital Platelet Defects

D. Morozova1, A. Martyanov2,3, D. Fedorova3, P. Zharkov3, M. Panteleev2,3, A. Shcherbina3, A. Sveshnikova2,3,4

Abstract Number: PB1432

A Challenging Case of Delayed-onset Refractory Heparin-induced Thrombocytopenia Complicated with Arterial Thrombosis

S. Van de Vondel

Abstract Number: PB1365

A Long Term Survival Chronic DIC with ITP Treated with Low Dose Steroid

Y. Seki, O. Nagano

Abstract Number: PB1434

A Novel Missense Mutations of the WASp Gene Cause a Familial X-linked Thrombocytopenia

H. Liu1, J. Ma1, R. Wu2

Abstract Number: PB1551

A Retrospective Study to Evaluate the Efficacy and Safety of a Plasma-Derived, von Willebrand Factor-Containing FVIII Concentrate, in Patients with Von Willebrand Disease (VWD) in Spain: Interim Analysis Results

V. Jiménez-Yuste1, R. Mir2

Abstract Number: PB1369

A Subpopulation of ITP Patients Resembling Glanzmann Thrombasthenia Phenotype Revealed by Flow Cytometry Analysis of Platelet Intracellular Signalling

A. Martyanov1,2,3, D.S. Morozova4, S.S. Uzueva3, M.A. Sorokina3, D.V. Fedorova3, P.A. Zharkov3, M.A. Panteleev2,3,5, A.N. Sveshnikova2,3,5

Abstract Number: PB1485

A Whole Blood Flow Cytometric Method for Diagnosis of Platelet Function Disorders

R.G. Dave1, T. Geevar1, R. V.1, S. Singh1, A. Abraham2, A. Srivastava2, S.C. Nair1

Abstract Number: PB1335

Achieving Clinically Relevant Platelet Count Response Thresholds with Avatrombopag (AVA) in Immune Thrombocytopenia (ITP)

I. Altomare1, M. Vredenburg2, W. Tian2, K. Aggarwal2

Abstract Number: PB1583

Acquired von-Willebrand-Disease (aVWD) in ECMO Patients: a 3-Year Cohort Study

T. Bajorat1, B. Panholzer2, A. Haneya2, D. Kowalski1, D. Juhl3, A. Rocke1, M. Shneyder1, P.M. Kuta1, H. Clausnizer1, U. Nowak-Göttl1

Abstract Number: PB1429

Addition of Exogenous Platelet Factor 4 in the Heparin Induced Platelet Activation (HIPA) Assay for the Detection of Pathogenic Heparin-induced Thrombocytopenia Antibodies

D. Faille, M.-C. Bourrienne, N. Ajzenberg

Abstract Number: PB1570

Adolescent Menorrhagia and Von Willebrand Disease

Y. Ouarhlent, M.R. Makhloufi

Abstract Number: PB1431

Anaphylactic Shock to Apixaban in a Patient Treated for Heparin-induced Thrombocytopenia (HIT)

M. Afonso1, A.G. Lopes2, R. Cardoso Araújo3, M. Vasconcelos3, A.P. Barbosa1, A. Marques1

Abstract Number: PB1377

Antimicrobial Prophylaxis in Patients with Immune Thrombocytopenia Treated with Rituximab: A Retrospective Multicenter Analysis

S. Raso1, M. Napolitano2, G. Arrigo1, F. Reale1, P. Silimbiani3, A. Lucchesi4, A. Maggio5, G. Calvaruso5, U. Consoli6, M.F. Mansueto1, S. Siragusa2

Abstract Number: PB1469

Antithrombotic Therapy by Charged Nanoparticles

M. Griffin1, K. Ashworth2, J. Di Paola2, D. Ku1

Abstract Number: PB1327

Antithyroid Treatment Improves Thrombocytopenia in a Young Patient with Graves´ Disease: A Case Report

V.V. Palmieri, G. Lassandro, A. Amoruso, V. Palladino, C. Pastore, P. Giordano

Abstract Number: PB1328

Apoptotic Markers May Help in Predicting the Disease Course of Pediatric Immune Thrombocytopenic Patients

S. Levy Mendelovich1, S. Aviner2, N. Sharon3, H. Miskin4, J. Yacobovich5, G. Kenet1, H. Hauschner6, N. Rosenberg1

Abstract Number: PB1366

Artificial Neural Network for Prediction of Hemorrhagic Severity in Patients with Immune Thrombocytopenia Purpura

L.P. de Carvalho1, M.P. Colella2, J.M. Annichino-Bizzacchi3, T.D. Martins4

Abstract Number: PB1481

Assessment of Platelet Function after Shear Stress Simulation Using an ex vivo Model for Extracorporeal Circulation

O. Hidiatov1, I. Marini1, L. Pelzl1, F. Rigoni1, M. Wagner1, A. Straub2, T. Bakchoul1,3

Abstract Number: PB1408

Assessment of the Hemostatic System by Total Thrombus-formation Analysis System (T-TAS) in Patients with Chronic Coronary Syndromes

O. Sirotkina1,2, I. Nazarova1, O. Melnichnikova1, A. Panov1, T. Vavilova1

  • 1
  • 2
  • 3
  • …
  • 13
  • Next Page »

« View all themes from the ISTH 2020 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley